Related Experiment Videos
The toxicology of 1-acetyl-2-methyl-2-formyl hydrazine (Ac-MFH)
Abstract:
The hepatotoxic and cancerogenic N-methyl-N-formyl hydrazine (MFH), which is formed from the mushroom poison, gyromitrin, by hydrolytic cleavage in vivo and in vitro during food processing, loses its hepatotoxicity and its influence on the renal function of rats after acetylation at the free NH2-moiety. The importance of MFH-acetylation with regard to an inhibition of microsomal conversion of MFH into a toxic nitrosamide is considered. The known genetically determined heterogeneity of the acetylation rate for hydrazine derivates in man may explain the observed differences in sensitivity towards the mushroom toxins.
Insights
Acetylation of N-methyl-N-formyl hydrazine (MFH) detoxifies this mushroom toxin, preventing liver damage and kidney dysfunction in rats. This process inhibits toxic nitrosamide formation, explaining varying human sensitivity to mushroom toxins.
Area of Science:
- Toxicology
- Biochemistry
- Pharmacology
Background:
- Gyromitrin, a mushroom poison, hydrolyzes to N-methyl-N-formyl hydrazine (MFH) in vivo and during food processing.
- MFH is hepatotoxic and cancerogenic, affecting renal function in rats.
Purpose of the Study:
- To investigate the detoxification mechanism of MFH through acetylation.
- To explore the role of MFH acetylation in inhibiting the formation of toxic nitrosamides.
- To correlate acetylation rates with observed differences in sensitivity to mushroom toxins.
Main Methods:
- Acetylation of MFH at the NH2-moiety in rats.
- Assessment of hepatotoxicity and renal function following MFH exposure and acetylation.
- Consideration of the inhibition of microsomal conversion of MFH to nitrosamide.
Main Results:
- Acetylation of MFH at the free NH2-moiety abolished its hepatotoxicity and effects on renal function in rats.
- MFH-acetylation is proposed to inhibit the conversion of MFH into a toxic nitrosamide by microsomes.
- Genetic variations in acetylation rates for hydrazine derivatives in humans may explain differential sensitivity to mushroom toxins.
Conclusions:
- Acetylation serves as a crucial detoxification pathway for N-methyl-N-formyl hydrazine.
- Inhibition of toxic nitrosamide formation via MFH acetylation is a key mechanism of detoxification.
- Individual differences in acetylation capacity can influence susceptibility to mushroom-derived toxins.